Total Payments
$69,656
2023 Payments
$2,429
Companies
31
Transactions
292
Medicare Patients
4,754
Medicare Billing
$2.3M
Payment Breakdown by Category
Other$48,620 (69.8%)
Consulting$9,077 (13.0%)
Food & Beverage$6,816 (9.8%)
Travel$4,865 (7.0%)
Education$277.63 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $48,620 | 39 | 69.8% |
| Consulting Fee | $9,077 | 12 | 13.0% |
| Food and Beverage | $6,816 | 215 | 9.8% |
| Travel and Lodging | $4,865 | 20 | 7.0% |
| Education | $277.63 | 6 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $53,507 | 100 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $8,226 | 29 | $0 (2023) |
| Amgen Inc. | $2,063 | 9 | $0 (2023) |
| Medtronic, Inc. | $1,991 | 13 | $0 (2023) |
| Veran Medical Technologies, Inc. | $1,173 | 4 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $639.57 | 22 | $0 (2023) |
| GlaxoSmithKline, LLC. | $350.37 | 34 | $0 (2023) |
| Genentech USA, Inc. | $337.96 | 14 | $0 (2022) |
| Actelion Pharmaceuticals US, Inc. | $236.94 | 10 | $0 (2023) |
| GENZYME CORPORATION | $148.19 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $2,429 | 36 | Medtronic, Inc. ($1,991) |
| 2022 | $25,379 | 127 | AstraZeneca Pharmaceuticals LP ($16,518) |
| 2021 | $18,694 | 36 | AstraZeneca Pharmaceuticals LP ($16,210) |
| 2020 | $4,688 | 19 | AstraZeneca Pharmaceuticals LP ($4,600) |
| 2019 | $16,017 | 49 | AstraZeneca Pharmaceuticals LP ($14,496) |
| 2018 | $1,653 | 12 | AstraZeneca Pharmaceuticals LP ($1,564) |
| 2017 | $795.90 | 13 | Boehringer Ingelheim Pharmaceuticals, Inc. ($313.51) |
All Payment Transactions
292 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/21/2023 | Medtronic, Inc. | ILLUMISITE (Device) | Travel and Lodging | In-kind items and services | $127.28 | General |
| Category: Interventional Lung Solutions | ||||||
| 07/20/2023 | Medtronic, Inc. | ILLUMISITE (Device) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Interventional Lung Solutions | ||||||
| 07/19/2023 | Medtronic, Inc. | ILLUMISITE (Device) | Travel and Lodging | In-kind items and services | $244.00 | General |
| Category: Interventional Lung Solutions | ||||||
| 07/19/2023 | Medtronic, Inc. | ILLUMISITE (Device) | Travel and Lodging | In-kind items and services | $179.44 | General |
| Category: Interventional Lung Solutions | ||||||
| 07/19/2023 | Medtronic, Inc. | ILLUMISITE (Device) | Travel and Lodging | In-kind items and services | $149.44 | General |
| Category: Interventional Lung Solutions | ||||||
| 07/19/2023 | Medtronic, Inc. | ILLUMISITE (Device) | Food and Beverage | In-kind items and services | $119.12 | General |
| Category: Interventional Lung Solutions | ||||||
| 07/19/2023 | Medtronic, Inc. | ILLUMISITE (Device) | Travel and Lodging | In-kind items and services | $18.36 | General |
| Category: Interventional Lung Solutions | ||||||
| 07/19/2023 | Medtronic, Inc. | ILLUMISITE (Device) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Interventional Lung Solutions | ||||||
| 07/19/2023 | Medtronic, Inc. | ILLUMISITE (Device) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: Interventional Lung Solutions | ||||||
| 07/18/2023 | Medtronic, Inc. | ILLUMISITE (Device) | Travel and Lodging | In-kind items and services | $234.00 | General |
| Category: Interventional Lung Solutions | ||||||
| 07/18/2023 | Medtronic, Inc. | ILLUMISITE (Device) | Travel and Lodging | In-kind items and services | $17.61 | General |
| Category: Interventional Lung Solutions | ||||||
| 07/17/2023 | Medtronic, Inc. | ILLUMISITE (Device) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Interventional Lung Solutions | ||||||
| 07/11/2023 | Medtronic, Inc. | ILLUMISITE (Device) | Travel and Lodging | In-kind items and services | $838.29 | General |
| Category: Interventional Lung Solutions | ||||||
| 04/18/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Immunology | ||||||
| 04/06/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: RESPIRATORY | ||||||
| 04/04/2023 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Pulmonology | ||||||
| 04/04/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/22/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/17/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/16/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: RESPIRATORY | ||||||
| 03/14/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: IMMUNOLOGY | ||||||
| 03/11/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/01/2023 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Pulmonology | ||||||
| 02/22/2023 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Inflammation | ||||||
| 02/21/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 545 | 7,201 | $765,374 | $209,587 |
| 2022 | 24 | 1,443 | 13,713 | $2.0M | $630,924 |
| 2021 | 22 | 1,286 | 18,010 | $1.8M | $647,926 |
| 2020 | 25 | 1,480 | 22,890 | $2.0M | $768,239 |
Total Patients
4,754
Total Services
61,814
Medicare Billing
$2.3M
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2357 | Injection, omalizumab, 5 mg | Office | 2023 | 30 | 3,705 | $370,500 | $110,061 | 29.7% |
| J2182 | Injection, mepolizumab, 1 mg | Office | 2023 | 23 | 2,600 | $260,000 | $60,121 | 23.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 188 | 236 | $58,056 | $19,526 | 33.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 29 | 96 | $10,752 | $3,798 | 35.3% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 30 | 96 | $10,560 | $3,374 | 32.0% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 28 | 90 | $13,500 | $3,202 | 23.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 66 | 192 | $12,096 | $2,122 | 17.5% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 19 | 54 | $5,670 | $1,569 | 27.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $6,048 | $1,555 | 25.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 18 | $3,168 | $1,212 | 38.3% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 28 | 28 | $4,424 | $935.66 | 21.1% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 28 | 28 | $4,424 | $782.93 | 17.7% |
| 92526 | Treatment of swallowing and feeding disorder | Office | 2023 | 12 | 12 | $2,052 | $734.36 | 35.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 22 | 22 | $3,344 | $401.07 | 12.0% |
| 97129 | Therapy procedure for a range of mental processes, initial 15 minutes | Office | 2023 | 12 | 12 | $780.00 | $194.92 | 25.0% |
| J0517 | Injection, benralizumab, 1 mg | Office | 2022 | 32 | 1,830 | $712,500 | $238,022 | 33.4% |
| J2357 | Injection, omalizumab, 5 mg | Office | 2022 | 40 | 4,935 | $477,000 | $148,031 | 31.0% |
| J2182 | Injection, mepolizumab, 1 mg | Office | 2022 | 27 | 4,300 | $403,000 | $98,266 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 359 | 684 | $168,264 | $64,927 | 38.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 39 | 269 | $30,128 | $12,508 | 41.5% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 41 | 245 | $36,750 | $10,351 | 28.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 84 | 84 | $35,616 | $10,167 | 28.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 42 | 258 | $28,380 | $9,815 | 34.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 54 | 54 | $27,216 | $7,010 | 25.8% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 113 | 114 | $18,012 | $5,216 | 29.0% |
About Dr. Adam Kaiser, MD
Dr. Adam Kaiser, MD is a Critical Care Medicine healthcare provider based in North Chesterfield, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2010. The National Provider Identifier (NPI) number assigned to this provider is 1972823177.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adam Kaiser, MD has received a total of $69,656 in payments from pharmaceutical and medical device companies, with $2,429 received in 2023. These payments were reported across 292 transactions from 31 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($48,620).
As a Medicare-enrolled provider, Kaiser has provided services to 4,754 Medicare beneficiaries, totaling 61,814 services with total Medicare billing of $2.3M. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location North Chesterfield, VA
- Active Since 06/10/2010
- Last Updated 05/20/2021
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1972823177
Products in Payments
- FASENRA (Biological) $21,223
- FASENRA (Drug) $20,388
- TEZSPIRE (Biological) $8,680
- DUPIXENT (Biological) $5,685
- ILLUMISITE (Device) $1,991
- Spin (Device) $1,173
- OFEV (Drug) $405.21
- NUCALA (Biological) $168.29
- TRELEGY ELLIPTA (Drug) $165.07
- STIOLTO RESPIMAT (Drug) $138.95
- SYMBICORT (Drug) $128.13
- UPTRAVI (Drug) $127.84
- LINX Reflux Management System (Device) $117.12
- Esbriet (Biological) $107.06
- (8874) inCourage (Device) $91.71
- Xolair (Biological) $86.70
- GLASSIA (Biological) $81.60
- Arikayce (Drug) $76.09
- Yupelri (Drug) $75.66
- Prolastin-C Liquid (Biological) $69.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in North Chesterfield
Michael Polsky, M.d, M.D
Critical Care Medicine — Payments: $36,599
Critical Care Medicine $36,599
Dr. Alice Herlihy, Md, MD
Critical Care Medicine — Payments: $18,395
Critical Care Medicine $18,395
Dr. Jamie Hey, M.d, M.D
Critical Care Medicine — Payments: $8,537
Critical Care Medicine $8,537
Dr. Alexander Flaxman, Md, Mse, MD, MSE
Critical Care Medicine — Payments: $640.02
Critical Care Medicine $640.02
Anthony Roesch, Crna, CRNA
Critical Care Medicine — Payments: $36.67
Critical Care Medicine $36.67
Scott Benson, Ag-Acnpc, AG-ACNPC
Critical Care Medicine — Payments: $35.91
Critical Care Medicine $35.91